Showing results (321-330 of 3,017) with videos related to
Sort By:
Pageof 302
Current Pharmaceutical Biotechnology|April 7, 2011
Metabolic profiling in multiple sclerosis and other disorders by quantitative analysis of cerebrospinal fluid using nuclear magnetic resonance spectroscopyN W Lutz, P J CozzoneCurrent Pharmaceutical Biotechnology|April 7, 2011
Altered metabolism and newborn screening using tandem mass spectrometry: lessons learned from the bench to bedsideDonald H Chace, Alan R SpitzerCurrent Pharmaceutical Biotechnology|April 8, 2011
Signal transduction pathways provide opportunities to enhance HDL and apoAI-dependent reverse cholesterol transportVishwaroop Mulay, Peta Wood, Carles Rentero, et al.Current Pharmaceutical Biotechnology|April 8, 2011
ATP binding cassette transporter A1 (ABCA1) associated proteins: potential drug targets in the metabolic syndrome and atherosclerotic disease?Christa Buechler, Sabrina BauerCurrent Pharmaceutical Biotechnology|April 8, 2011
Cellular cholesterol efflux pathways: impact on intracellular lipid trafficking and methodological considerationsIlaria Zanotti, Elda Favari, Franco BerniniCurrent Pharmaceutical Biotechnology|April 8, 2011
Role of MMPs in metastatic dissemination: implications for therapeutic advancesD Raffo, O Pontiggia, M SimianCurrent Pharmaceutical Biotechnology|April 8, 2011
Metastatic cancer stem cells: new molecular targets for cancer therapyG J Leirós, M E BalañáCurrent Pharmaceutical Biotechnology|April 8, 2011
Epithelial-mesenchymal transition: implications in cancer progression and metastasisL R Gomes, L F Terra, M C Sogayar, et al.Current Pharmaceutical Biotechnology|April 8, 2011
The pros and cons of targeting protein kinase C (PKC) in the management of cancer patientsF Coluccio Leskow, M A Krasnapolski, A J UrtregerCurrent Pharmaceutical Biotechnology|April 8, 2011
Cross-talk between tumor cells and the microenvironment at the metastatic nicheM J Carlini, M S De Lorenzo, L PuricelliPageof 302